Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
304,692
Value
$165.1M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of UTHR by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026304,692$165.1M0.1%−55,951−15.5%ReducedHolders
Q1 2026360,643$213.9M0.2%+173,479+92.7%AddedHolders
Q4 2025187,164$91.2M0.1%−86,818−31.7%ReducedHolders
Q3 2025273,982$114.9M0.1%+132,971+94.3%AddedHolders
Q2 2025141,011$40.5M<0.1%+104,827+289.7%AddedHolders
Q1 202536,184$11.2M<0.1%+15,846+77.9%AddedHolders
Q4 202420,338$7.18M<0.1%+20,338NewHolders
Q2 20240$00.0%−719,311−100.0%Sold outHolders
Q1 2024719,311$165.2M0.2%+641,414+823.4%AddedHolders
Q4 202377,897$17.1M<0.1%+56,825+269.7%AddedHolders
Q3 202321,072$4.76M<0.1%−22,252−51.4%ReducedHolders
Q2 202343,324$9.56M<0.1%−10,776−19.9%ReducedHolders
Q1 202354,100$12.1M<0.1%−270,831−83.4%ReducedHolders
Q4 2022324,931$90.4M0.1%−289,581−47.1%ReducedHolders
Q3 2022614,512$128.7M0.2%+555,159+935.4%AddedHolders
Q2 202259,353$14.0M<0.1%−174,171−74.6%ReducedHolders
Q1 2022233,524$41.9M<0.1%+114,607+96.4%AddedHolders
Q4 2021118,917$25.7M<0.1%−202,582−63.0%ReducedHolders
Q3 2021321,499$59.3M0.1%+82,426+34.5%AddedHolders
Q2 2021239,073$42.9M<0.1%−80,538−25.2%ReducedHolders
Q1 2021319,611$53.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.